FOLH1 and vascular malformation: In addition to inflammation, high PSMA expression in other non-neoplastic lesions, such as vascular disease (vascular malformations/hemangiomas), focal nodular hyperplasia of the liver, and focal fatty liver, should be considered when assessing hepatic parenchymal lesions using PSMA PET (61, 63–65, 68).